• Hypertrophic Cardiomyopathy (HCM)
  • Vaccines: 2023 Year in Review
  • Eyecare
  • Urothelial Carcinoma
  • Women's Health
  • Hemophilia
  • Heart Failure
  • Vaccines
  • Neonatal Care
  • NSCLC
  • Type II Inflammation
  • Substance Use Disorder
  • Gene Therapy
  • Lung Cancer
  • Spinal Muscular Atrophy
  • HIV
  • Post-Acute Care
  • Liver Disease
  • Pulmonary Arterial Hypertension
  • Biologics
  • Asthma
  • Atrial Fibrillation
  • Type I Diabetes
  • RSV
  • COVID-19
  • Cardiovascular Diseases
  • Breast Cancer
  • Prescription Digital Therapeutics
  • Reproductive Health
  • The Improving Patient Access Podcast
  • Blood Cancer
  • Ulcerative Colitis
  • Respiratory Conditions
  • Multiple Sclerosis
  • Digital Health
  • Population Health
  • Sleep Disorders
  • Biosimilars
  • Plaque Psoriasis
  • Leukemia and Lymphoma
  • Oncology
  • Pediatrics
  • Urology
  • Obstetrics-Gynecology & Women's Health
  • Opioids
  • Solid Tumors
  • Autoimmune Diseases
  • Dermatology
  • Diabetes
  • Mental Health

Physician Proponent: Prescription Solutions' Brian Solow, MD, talks physician-PBM relationship

Article

The relationship between physicians and pharmacy benefit managers continues to change. A goal of Prescription Solutions' Brian Solow, MD, is to foster a collaborative approach to working with physicians, to ultimately deliver better care to patients.

During his tenure with Bristol Park Medical Group, a physician-owned primary care group in Irvine, he participated on multiple leadership committees while maintaining a family medicine practice. Over the years, Dr. Solow has gained knowledge of the PBM industry as a member of the national pharmacy and therapeutics committees of various PBMs.

"I reach out to doctors and find out how we can become their partners and not interfere with their practices," Dr. Solow says. "We need them to recognize the true value of the PBM because a lot of physicians just see PBMs as another piece of the insurance puzzle. We know we can target the consumer, and the consumer can target the doctor. If we can get both parties onboard, we'll have better success implementing medi cation therapy management [MTM] and other clinical programs."

Q. What is your biggest challenge with managing pharmaceutical benefits?

We want them to understand that we are not trying to limit their utilization of medications, nor are we trying to limit choices, but rather are promoting the appropriateness of their prescription medications with a focus on the clinical quality. It's important that all stakeholders in the healthcare system work together to help patients lead healthy, productive lives.

Related Videos
Video 6 - "Navigating Insurance Coverage for Prescription Digital Therapeutics"
Video 5 - "FDA Approval Pathway for Prescription Digital Therapeutics"
Video 8 - "Gaps in Evidence Generation for Digital Therapeutics"
Video 7 - "Adoption Lessons For Payers"
Video 10 - "Managing Self Care"
Video 3 - "Embracing and Improving Access to Technology Tools"
Video 4 - "Assessing the Cost-Effectiveness of Prescription Digital Therapeutics "
© 2024 MJH Life Sciences

All rights reserved.